Concepedia

Author

M Zimmermann

Medizinische Hochschule Hannover

Also Known As

M Zimmermann, M. ZIMMERMANN, M. Zimmermann, Malenka Zimmermann, Martin Zimmermann, Zuzanna A. Kolodynska

121

Publications

6.6K

Citations

39

H-Index

51

Concepts

All Affiliations

Medizinische Hochschule HannoverSt Anna Children's HospitalUniversity Hospital MünsterUniversity Hospital Schleswig-HolsteinUniversity of Lübeck
MZ

About

M Zimmermann is an author at Medizinische Hochschule Hannover specializing in medicine, hematology, and pediatrics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

22

26

3K

2

Health Sciences

3

3

702

3

Public Health

2

2

154

4

Natural Sciences

1

1

19

5

Allergy

1

1

27

M Zimmermann

×

50

Publications

5.5K

Citations

35

H-Index

YearCitations

Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86

Alfred Reiter, Martin Schrappe, WD Ludwig,

Blood

1994

614

Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000

Anja Möricke, M Zimmermann, Alfred Reiter,

Leukemia

2009

520

Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia

T Flohr, André Schrauder, Giovanni Cazzaniga,

Leukemia

2008

357

Mutations in KIT and RAS are frequent events in pediatric core-binding factor acute myeloid leukemia

Bianca F. Goemans, Ch. M. Zwaan, Mitchell Miller,

Leukemia

2005

239

Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials

U. Creutzig, M Zimmermann, J. Ritter,

Leukemia

2005

228

Improved Treatment Results in High-Risk Pediatric Acute Myeloid Leukemia Patients After Intensification With High-Dose Cytarabine and Mitoxantrone: Results of Study Acute Myeloid Leukemia–Berlin-Frankfurt-Münster 93

Ursula Creutzig, J. Ritter, M Zimmermann,

Journal of Clinical Oncology

2001

200

Clinical significance of surface antigen expression in children with acute myeloid leukemia: results of study AML-BFM-87

Ursula Creutzig, Jochen Harbott, Christian Sperling,

Blood

1995

171

IKZF1 deletion is an independent predictor of outcome in pediatric acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol

Petra Dörge, Barbara Meissner, M Zimmermann,

Haematologica

2012

165

Definition of a standard‐risk group in children with AML

Ursula Creutzig, M Zimmermann, J. Ritter,

British Journal of Haematology

1999

153

NUP98/JARID1A is a novel recurrent abnormality in pediatric acute megakaryoblastic leukemia with a distinct HOX gene expression pattern

Jasmijn de Rooij, Iris H.I.M. Hollink, Susan T.C.J.M. Arentsen-Peters,

Leukemia

2013

150

Page 1